Navigation Links
Pharmacogenomics in Medical News

New Study Shows That Pharmacogenomics Could Benefit Patients, Spur Investment in Innovation

WASHINGTON, Aug. 3 /PRNewswire-USNewswire/ -- A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics -- the field of scientific research focused on learning how genetic profiles predict the body's response to medicines - has the potential to lead to h...

GeneGo Awarded NIH Grant to Develop Pharmacogenomics Software Suite

ST. JOSEPH, Mich., July 28 /PRNewswire/ -- GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant to develop an integrated systems pharmacology platform for pharmacogenomic research. The SBIR grant, funded through the innovations in ...

Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?

In this weeks press release: Could anemia be used to assess the burden and control of neglected tropical diseases" Translating pharmacogenomics: challenges on the road to the clinic Please mention PLoS Medicine in your report and use the links below to take your readers straight to...

UC San Diego to lead nationwide program in pharmacogenomics

The Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, will collaborate with the American Pharmacists Association, the American Society of Health-System Pharmacists, and the American Association of Colleges of Pharmacy to promote PharmGenEd, in an edu...

Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics

Collaboration to Explore Clinical Uses of Personal Genetics and Tamoxifen FRANKLIN LAKES, NJ and BURLINGTON, NC, Oct. 22 /PRNewswire-FirstCall/ -- Medco Health Solutions Inc. (NYSE: MHS ) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH ) announced a strategic research...

Special One-Day Rates Available For DIA 45th Annual Meeting June 21-25 in San Diego

...Landscape Current event sessions Hot topics! Phase 1 Early Development, Accelerated Development Time, US FDA Sentinel Initiative, Transparency, pharmacogenomics and Personalized Medicines and much more! Pharma in the New Age of Transparency Meet the Regulators CDER Town Meeting Parts 1 and 2 Europ...

'Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis'

...ort within the industry. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the c...

Ambry Genetics Announces Illumina CSPro Certification for GA Sequencing

... Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies. To lear...

Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument

...he development of personalized medicine, says Randall Lambrecht, Ph.D., Aurora's vice president of research and academic relations. "The field of pharmacogenomics aims to find a way to determine the most effective drug for an individual with the fewest side effects, based on that person's genetic makeup," Lambre...

Medco Tops Fortune's Lists of 'World's Most Admired' Companies

... patient health and lowering overall medical costs. This is accomplished by partnering with member advocacy programs to engage and educate consumers, pharmacogenomics research that helps physicians in the selection of the right medicine and dose based on a patient's unique genetic make-up as well as other clinical i...
Pharmacogenomics in Medical Technology

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

...Systems Medicine, a privately-held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin

...cal development and drug combination studies by incorporating an integrated pharmacogenomics approach. The study was conducted by SM in collaboration with the Translati...erger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory e...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings inc..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma

...ms Medicine (SM), a privately held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability.'...

Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling

...ms Medicine (SM), a privately held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

New Gene Discovery Suggests Which Patients CTI's Brostallicin May Benefit

...ms Medicine (SM), a privately-held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability....

Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies

...ive Officer. "We are focused on generating continued strong momentum in our pharmacogenomics business and will continue fueling this growth through the recent addition ...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...

Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial

... http://www.pharmatech.com . About Systems Medicine LLC Systems Medicine, LLC (SML), develops oncology products by integrating predictive cellular pharmacogenomics ("genomics") with world-class clinical and regulatory expertise. This allows SML to develop patient-selective therapies by defining the context of vul...

Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)

... ROCKVILLE, Md., Feb. 29 /PRNewswire-FirstCall/ -- A study reported in the journal pharmacogenomics suggests that a genetic variation in the Ciliary Neurotrophic Factor gene (CNTF) may affect response to antipsychotic treatment. The study, conducted ...
Pharmacogenomics in Medical Definition

Medicine

...lems related to work and the working environment. Osteopathic medicine claims that much disease results from problems with bones and joints. pharmacogenomics is a form of individualized medicine . PanVascular Medicine is an approach to deal with the problems of highly specialised but both, medical ...

Personalized medicine

...e W, Dai Z. (2005), Pharmacogenetics/genomics and personalized medicine, Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R207-14. Steven H. Y. Wong (2006), pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine, American Association for Clinical Chemistry, ISBN 1-59425-046-4 External l...
Pharmacogenomics in Biological News

Launching a global alliance for pharmacogenomics

Leaders at the National Institutes of Health and the Center for Genomic Medicine in Japan have signed a letter of intent creating a Global Alliance for Pharmacogenomics. The effort aims to identify genetic factors that contribute to individual responses to medicines, including rare and dangerous s...

At Boston symposium, NARSAD researchers report on genes and family traits

...s may cause suicidal thinking and behavior in children, adolescents and adults ages 18 to 24. According to Roy Perlis, M.D., M.Sc., the director of pharmacogenomics research at Massachusetts General Hospital's Department of Psychiatry, specific genes may influence how individual patients respond to antidepressant ...

Many African-Americans have a gene that prolongs life after heart failure

...ents," says senior author Gerald W. Dorn II, M.D., professor of medicine, associate chairman for translational research and director of the Center for pharmacogenomics at Washington University. "By mimicking the effect of beta blockers, the genetic variant makes it appear as if beta blockers aren't effective in t...

Genetic variant mimics effect of heart failure medications

... patients, says co-author Gerald W. Dorn II, M.D., professor of medicine, associate chairman for translational research and director of the Center for pharmacogenomics at Washington University. By mimicking the effect of beta-blockers, the genetic variant makes it appear as if beta blockers arent effective in these...

AIBS to cohost symposium on evolution, disease and human health

...s, as well as policies around the use of racial taxonomies by publicly funded cell repositories. Her current project, Race and Distributive Justice in pharmacogenomics Research, includes the development of an anthropology of racial justice, with a particular focus on health disparities among populations. Davi...

UNC study questions FDA genetic-screening guidelines for cancer drug

...ven that low doses of the drug werent causing problems, said Howard McLeod, Pharm.D., senior author of the study and director of the UNC Institute for pharmacogenomics and Individualized Therapy. Our review showed that at low doses the drug is well tolerated and can be taken by most people, McLeod said. As the dos...

Large-scale genomics project will hunt genes behind common childhood diseases

...e company's important genome-wide mapping and association studies over the past several years, and served as director of Respiratory, Inflammatory and pharmacogenomics Research, vice president of Clinical Sciences, and later as vice president of Business Development. "Our goals for the Center are to generate new d...

St. Jude projects 90 percent cure rate for ALL

...ent," Evans said. "That's why the breakthroughs in pharmacogenomics made at St. Jude and elsewhere are so important. T...ng a lot of guesswork instead of good science." pharmacogenomics is the study of the effects of different genes on ...t in diagnosis and treatment made possible by MRD, pharmacogenomics and new drug therapies has shifted the focus in AL...

Mammalian Transcriptome Mapped

... works. "This is arguably the next major step after the human genome project," says Professor Claes Wahlestedt, M.D., Ph.D., who is the director of pharmacogenomics at Scripps Florida. Wahlestedt is also a professor at the Karolinska Institute in Sweden, and is adjunct chief scientist at RIKEN Institutes, Japan. "...

NIH renews network focused on how genes influence drug responses

...totals for each award. The Pharmacogenetics and pharmacogenomics Knowledge Base ( PharmGKB )--$13.7 million provide...ncisco) Consortium on Breast Cancer pharmacogenomics --$11.6 million provided by NIGMS, NIEHS, and ORWH... St. Jude Children's Research Hospital) pharmacogenomics of Arrhythmia Therapy --$14 million provided by NH...
Pharmacogenomics in Biological Technology

Transgenomic Opens Pharmacogenomics Laboratory in China

Provides New Opportunity to Serve Pharmaceutical Partner Interest for Clinical Trials in China OMAHA, Neb., March 31 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a global genetic analysis and services company, today announced that it has ente...

Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference

- Presentation to be Webcast as Part of AACR Virtual Meeting - LOS ANGELES, Oct. 19 /PRNewswire-FirstCall/ -- Response Genetics, Inc. (Nasdaq: RGDX ) today announced that Kathleen Danenberg, the Company's President and Chief Executive Officer, will give a presentation on the role of phar...

Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE((R)) DHPLC Syste...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Transgenomic, Inc. Announces Appointment of New Board Members

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Transgenomic, Inc. Reports First Quarter 2009 Results

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...

Webcast Alert: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast

...l research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems...automated systems, Transgenomic Molecular Clinical Reference Laboratory and pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize...

Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine

...Aliso Viejo, California. Since the company's inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the c...

Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations

...ratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings incl..., Cytogenetics automated systems, and Transgenomic pharmacogenomics and Reference Laboratory Services. Transgenomic pharmacogenomics and Laboratory Services utilize their technology a...
Pharmacogenomics in Biological Products

Functional Genomics & Pharmacogenomics from Dominion Pharmakine S.L.

Description: Gene expression profiling allows a high-throuput screening of a biological systems phenotype, so that naturally occuring or artifitially induced changes in the expression levels of the genes in that system can be detected, studied, classified and compared to each other, covering a broad range of ge...
Company:Dominion Pharmakine S.L.
Pharmacogenomics in Biological Definition

Promoter

... diseases respond differently to treatment as a result of differences in the underlying molecular origins is partially addressed by the discipline of pharmacogenomics . Asthma population genetics study: Hobbs, K.; Negri, J.; Klinnert, M.; Rosenwasser, L.J.; and Borish, L. (1998). Interleukin-10 and tra...
Pharmacogenomics in Biological Dictionary

Polymorphisms

... suite of products in the ... Polymorphisms ... Single Nucleotide Polymorphisms - SNPs - SNP genotyping information and resources available for pharmacogenomics - Building on the Human Genome Project Methylenetetrahydrofolate reductase (MTHFR) is 'a critical enzyme in both folate and homocysteine metaboli...

Membrane transporter

... Transporter Glossary. Relevant Databases and Web Sources. Transporter pharmacogenomics ... Membrane Transporter pharmacogenomics ... The apical membrane contains the sodium-glucose cotransporter SGLU...
Other Tags
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ... platform to think outside the bra. She doesn’t try to ... raise awareness about women’s other lady parts. , "We have ... the color pink and everybody knows what you’re talking about,” ... it has not been won when it comes to gynecologic ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Final Cut Pro ... release of the Citrus theme for FCPX filmmakers . ... use to describe the Citrus theme” Says Christina Austin, CEO ... to look so professional.” , Citrus comes with all the ... the template are: four transitions for added style, a title ...
(Date:10/20/2014)... 2014 Do you ever feel difficulty ... a wonderful app Metassessor for teachers, specialists and parents. ... helped its client “Intervention Development LLC” to launch Metassessor ... designed for iOS 4.3 or later and is Compatible ... optimized for iPhone 5. It is now available on ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
(Date:10/14/2014)... Like discriminating thieves, prostate cancer tumors scavenge and hoard ... But such avarice may be a fatal weakness. ... to kill prostate cancer cells by delivering a trove ... the diseased cells brimming with the mineral, leaving non-cancer ... drugs already commercially available for other uses, could soon ...
(Date:10/14/2014)... Mount Sinai-led research team has discovered a new kind of ... a cell that lines liver blood vessels, according to a ... . The existence of such a cell type contradicts current ... embryo, and may hold clues to origins of, and future ... from a single cell into a complex being made up ...
(Date:10/14/2014)... cancer likely takes between 10 and 20 years ... "broad window" of intervention if detected early, which ... predisposition, say Australian clinical researchers. , Dr ... Garvan Institute of Medical Research, analysed medical histories ... 766 pancreatic cancer patients, operated on between 1994 ...
Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3Early detection window when pancreatic cancer is in the family 2
Other Contents